Navigation Links
DURECT in Medical News

Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT

CUPERTINO, Calif., Feb. 27 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX ) today reported that Endo Pharmaceuticals (Nasdaq: ENDP ) has given notice that it is returning to us Endo's rights in the U.S. and Canada to develop and commercialize TRANSDUR(TM)-Sufentanil, a propriet...

DURECT Corporation Announces Second Quarter 2009 Financial

...UPERTINO, Calif., Aug. 3 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today fina.../prnh/20020717/DRRXLOGO ) At June 30, 2009, durect had cash and investments of $41.9 million, compare...(TM) (SABER(TM)-Bupivacaine). During the quarter, durect continued enrollment in our approximately 6...

DURECT to Present at the BMO Capital Markets Healthcare Conference

...PERTINO, Calif., July 28 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that...com/cgi-bin/prnh/20020717/DRRXLOGO ) About durect Corporation durect is an emerging specialty pharmaceutical company de...

DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call

... 27 /PRNewswire-FirstCall/ -- In conjunction with durect Corporation's (Nasdaq: DRRX ) second quarter 200...in the "Investor Relations" section. About durect Corporation durect is an emerging specialty pharmaceutical company de...

REMOXY(R) NDA Update

...UPERTINO, Calif., July 7 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) today reported that ... Corporate Relationships In December 2002, durect licensed to Pain Therapeutics, Inc. the right to d...ied opioid compounds. Under the license agreement, durect is reimbursed for formulation and other work perfo...

DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy

...PERTINO, Calif., June 16 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that Dr. Joseph Stauffer has joined durect as Chief Medical Officer and Executive Vice Presid...ucts," stated James E. Brown, President and CEO of durect Corporation. "We're looking forward to the impact...

DURECT Corporation Invites You to Join its First Quarter 2009 Earnings Conference Call

...l 28 /PRNewswire-FirstCall/ -- In conjunction with durect Corporation's (Nasdaq: DRRX ) first quarter 2009...n the "Investor Relations" section. About durect Corporation durect is an emerging specialty pharmaceutical company de...

DURECT to Participate in Cowen and Company Healthcare Conference

...PERTINO, Calif., March 9 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that...e in the "Investor Relations" section. About durect Corporation durect is an emerging specialty pharmaceutical company de...

Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results

...nt of oral mucositis, was on clinical hold, while EN 3270 was licensed from durect Corporation and in Phase II development for the treatment of moderate-to-severe chronic pain. Endo will return to durect all development rights to its transdermal sufentanil patch. 2009 Fina...

DURECT Corporation Invites You to Join Its Fourth Quarter 2008 Earnings Conference Call

...b. 2 /PRNewswire-FirstCall/ -- In conjunction with durect Corporation's (Nasdaq: DRRX ) fourth quarter 200...e in the "Investor Relations" section. About durect Corporation durect is an emerging specialty pharmaceutical company de...
DURECT in Medical Technology

ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia

CUPERTINO, Calif., June 30 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX ) announced today that the US Food and Drug Administration (FDA) has granted to DURECT orphan drug designation for bupivacaine for relief of persistent pain associated with post-herpetic neuralgia (PHN). Bup...

DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program

...ERTINO, Calif., March 16 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today posi...therapy," stated James Brown, President and CEO of durect Corporation. "We believe that our small, patient-...t to partner or to progress ourselves. About durect Corporation ...

REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted

...PERTINO, Calif., Aug. 12 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ... release dosage forms on the market today. About durect Corporation durect is an emerging specialty pharmaceutical company de...

DURECT Announces Positive ELADUR(TM) Phase IIa Study Results

...PERTINO, Calif., Dec. 18 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today posit...d characteristics of analgesic activity of ELADUR. durect anticipates that detailed results will be submitte...lock, epidural and intrathecal anesthesia. About durect Corporation ...

Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM)

...UPERTINO, Calif., Dec. 6 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...dded benefit of being less prone to abuse. About durect Corporation durect Corporation is an emerging specialty pharmaceutica...

DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp

...nds among women, but no positive effect among men. durect has not independently verified the analysis perfor...eking a potential partner for the program. About durect Corporation durect Corporation is an emerging specialty pharmaceutica...
DURECT in Biological Technology

DURECT Corporation Announces Third Quarter 2008 Financial Results

...UPERTINO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today finan...les based milestones. If ELADUR is commercialized, durect would also receive royalties on product sales. Alp...chive in the "Investor Relations" section. About durect Corporation ...

DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective

...PERTINO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...arma Ireland Limited and DURECT, Alpharma has paid durect an upfront license fee of $20 million, with possib...les based milestones. If ELADUR is commercialized, durect would also receive a royalty on product sales. Alp...

New Drug Application Submitted for Remoxy(TM) (ORADUR(TM)-Based Oxycodone)

...PERTINO, Calif., June 10 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...er). Corporate Relationships In December 2002, durect licensed to Pain Therapeutics, Inc. the right to d...d drug candidates. In addition, if commercialized, durect will receive royalties for Remoxy and certain othe...

DURECT Corporation to Participate in Upcoming Healthcare Conferences

...UPERTINO, Calif., June 6 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...chive in the "Investor Relations" section. About durect Corporation durect Corporation is an emerging specialty pharmaceutica...

DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results

...UPERTINO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today finan...r the same period in 2006. At December 31, 2007, durect had cash and investments of $62.0 million, compare... over existing therapeutics." Highlights for durect in Fiscal Year 2007 include: -- Remoxy. In Dece...

DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call

.... 31 /PRNewswire-FirstCall/ -- In conjunction with durect Corporation's (Nasdaq: DRRX ) fourth quarter 2007...chive in the "Investor Relations" section. About durect Corporation durect Corporation is an emerging specialty pharmaceutica...

DURECT to Host Webcast in Conjunction with an Analyst's Day on October 17

...PERTINO, Calif., Oct. 16 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...wscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) About durect Corporation durect Corporation is an emerging specialty pharmaceutica...

Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIG's Plenary Panel in Vegas

...feTech Innovations -- Maggie Pax, Senior Director, Business Development, MicroCHIPS -- Michael Arenberg, Executive Director, Business Development, durect -- Fernando Alvarez-Nunez, PhD, Principal Scientist, Small Molecule Pharmaceutics, Amgen -- Ashutosh Sharma, PhD, Executive Vice President, V...

DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference

...PERTINO, Calif., Aug. 29 /PRNewswire-FirstCall/ -- durect Corporation (Nasdaq: DRRX ) announced today that ...rchive in the "Investor Relations" section. About durect Corporation durect Corporation is an emerging specialty pharmaceutica...
Other Tags
(Date:4/18/2014)... researchers have been awarded two-year grants for their work ... month. Of the 110 initial submissions to the new ... only four projects were funded, three of which are ... M.D., Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, ... oncology, will use his $500,000 proof of principle grant ...
(Date:4/18/2014)... new study in the American Journal of Preventive ... reveals a recurring pattern that could be leveraged to ... San Diego State University, the Santa Fe Institute, Johns ... searches (searches that included the term healthy and were ... from 2005 to 2012. They found that on average, ...
(Date:4/17/2014)... inflammation in non-cancerous prostate tissue may have nearly twice ... with no inflammation, according to results of a new ... Cancer Center. , The link between persistent inflammation and ... prostate cancer those with a Gleason score between ... most aggressive and rapidly growing prostate cancers. , "What ...
(Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
(Date:4/17/2014)... review published in the April issue of Immunity ... Institute for Medical Research, says it,s time to take ... to treating sepsis, which kills millions worldwide every ... when molecules released into the bloodstream to fight an ... is necessary for maintaining good health without inflammation, ...
Breaking Medicine News(10 mins):Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
(Date:4/20/2014)... 2014 -- Using corn crop residue to make ethanol ... more greenhouse gases than gasoline, according to a study ... . , The findings by a University of Nebraska-Lincoln ... can be used to meet federal mandates to ramp ... Corn stover -- the stalks, leaves and cobs in ...
(Date:4/18/2014)... researchers have published soil organic carbon sequestration rates. ... organic carbon can be sequestered by simply switching from ... there is a growing body of research with evidence ... cover crops, small grains, and forages may not be ... , "Some studies have shown that both moldboard and ...
(Date:4/18/2014)... team of researchers led by a University of California, ... a $7.5 million Department of Defense grant to uncover ... foundations for the predictable design of light-weight, tough and ... structures from plants and animals, including the mantis shrimp, ... systems have constructed over millions of years and coming ...
Breaking Biology News(10 mins):Study casts doubt on climate benefit of biofuels from corn residue 2Study casts doubt on climate benefit of biofuels from corn residue 3Researchers question published no-till soil organic carbon sequestration rates 2Researchers question published no-till soil organic carbon sequestration rates 3Researchers question published no-till soil organic carbon sequestration rates 4Mantis shrimp, toucan and trilobite, oh my 2Mantis shrimp, toucan and trilobite, oh my 3
Other Contents